Drugs / NPB-06
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02250391 | Sep 2014 → Mar 2016 | portal vein thrombosis | Nihon Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPB-06 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02250391 ↗ |
| Route | Intravenous | “will receive intravenous injection of NPB-06 or placebo” NCT02250391 ↗ |